IFN-γ receptor deletion prevents autoantibody production and glomerulonephritis in lupus-prone (NZB x NZW)F1 mice

Journal of Immunology

Volumn 160, Issue 8, 1998, Pages 3713-3718

  Haas, Cordula ^a   Ryffel, Bernhard ^b   Le Hir, Michel ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON RECEPTOR; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G3;

ANIMAL CELL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; AUTOIMMUNITY; B CELL LYMPHOMA; CYTOKINE PRODUCTION; FEMALE; GENE SWITCHING; GLOMERULONEPHRITIS; INCIDENCE; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, ANTINUCLEAR; AUTOANTIBODIES; BASE SEQUENCE; DISEASE MODELS, ANIMAL; DNA PRIMERS; FEMALE; IMMUNOGLOBULIN G; INTERFERON TYPE II; INTERLEUKIN-4; LUPUS NEPHRITIS; LYMPHOMA; MALE; MICE; MICE, INBRED NZB; MICE, KNOCKOUT; POLYMERASE CHAIN REACTION; RECEPTORS, INTERFERON; T-LYMPHOCYTES;

EID: 0032522778     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Theofilopoulos, A. N. 1992. Murine models of lupus. In Systemic Lupus Erythematosus, 2nd Ed., R. G. Lahitas, ed. Churchill Livingstone, New York, p. 121.
2. Theofilopoulos, A. N., and F. J. Dixon. 1981. Etiopathogenesis of murine SLE. Immunol. Rev. 55:179.
3. Andrews, B. S., R. A. Eisenberg, A. N. Theofilopoulos, S. Izui, C. B. Wilson, P. J. McConahey, E. D. Murphy, J. B. Roths, and F. J. Dixon. 1978. Spontaneous murine lupus-like syndromes. J. Exp. Med. 148:1198.
4. 1 mice. Lupus 4:213.
5. 1 mice. Scand. J. Immunol. 42:466.
6. 1 mice. J. Exp. Med. 179:305.
7. 1 mice. J. Clin. Invest. 94:585.
8. 1 mice. Am. J. Pathol. 144:927.
9. Santiago, M.-L., L. Fossati, C. Jacquet, W. Müller, S. Izui, and L. Reininger. 1997. Interleukin-4 protects against a genetically linked lupus-like autoimmune syndrome. J. Exp. Med. 185:65.
10. 1 lupus-like nephritis with monoclonal antibody to gamma interferon. J. Exp. Med. 166:798.
11. Ozmen, L., D. Roman, M. Fountoulakis, G. Schmid, B. Ryffel, and G. Garotta. 1995. Experimental therapy of systemic lupus erymematosus: the treatment of NZB/W mice with mouse soluble interferon-γ receptor inhibits the onset of glomerulonephritis. Eur. J. Immunol. 25:6.
12. 1 mice. Clin. Exp. Immunol. 40:373.
13. Huang, S., W. Hendriks, A. Althage, S. Hemmi, H. Bluethmann, R. Kamijo, J. Vilcek, R. M. Zinkernagel, and M. Aguet. 1993. Immune response in mice that lack the interferon-gamma receptor. Science 259:1742.
14. Jacob C O., F. Hwang, G. D. Lewis, and A. M. Stall. 1991. Tumor necrosis factor alpha in murine systemic lupus erythematosus disease models: implications for genetic predisposition and immune regulation. Cylokine 3:551.
15. Kopf, M., G. Le Gros, A. J. Coyle, M. Kosco-Vilbois, and F. Brombacher. 1995. Immune responses of IL-4, IL-5, IL-6 deficient mice. Immunol. Rev. 148:45.
16. + T cell response. J. Exp. Med. 181:961.
17. Haas, C., B. Car, B. Ryffel, and M. Le Hir. 1996. Lipopolysaccharide-induced glomerulonephritis develops in the absence of interferon-γ signaling. Exp. Nephrol. 4:222.
18. Peng, S. L., J. Moslehi, and J. Craft. 1997. Roles of interferon-γ and interleukin-4 in murine lupus. J. Clin. Invest. 99:1936.
19. Haas, C., B. Ryffel, and M. Le Hir. 1997. IFN-γ is essential for the development of autoimmune glomerulonephritis in MRL/lpr mice. J. Immunol. 158:5484.
20. 1 mice. Microbiol. Immunol. 37:221.
21. Phillips, J. A., K. Mehta, C. Femandez, and E. S. Raveché. 1992. The NZB mouse as a model for chronic lymphocytic leukemia. Cancer Res. 52:437.
22. + B cells in autoimmune disease and in chronic lymphocytic leukemia. Ann. N Y Acad. Sci. 651:509.
23. 1 mice. Eur. J. Immunol. 17:809.
24. z homozygous New Zealand mice as a model for B-cell chronic lymphocytic leukemia: elevated bcl-2 expression in CD5 B cells at premalignant and malignant stages. Jpn. J. Cancer Res. 84:1273.
25. Peng, B., D. H. Sherr, F. Mahboudi, J. Hardin, Y. Wu, L. Sharer, and E. S. Raveché. 1994. A cultured malignant B-1 line serves as a model for Richter's syndrome. J. Immunol. 153:1869.
26. - αβ T cells in the peritoneal cavity: specific T cell receptor-mediated cytotoxicity and selective IFN-γ production against B cell leukemia and myeloma cells. J. Immunol. 157:3925.
27. MacKenzie, M. R., T. Paglieroni, and V. Caggiano. 1991. CD5 positive immunoregulatory B cells in spleen populations from multiple myeloma patients. Am. J. Hematol. 37:163.
28. Reininger, L., T. Shibata, S. Schurmans, R. Merino, L. Fossati, M. Lacour, and S. Izui. 1990. Spontaneous production of anti-mouse red blood cell autoantibodies is independent of the polyclonal activation in NZB mice. Eur. J. Immunol. 20:2405.
29. + B cells of NZB origin. J. Immunol. 141:4133.
30. Haas, C., B. Ryffel, and M. Le Hir. 1995. Crescentic glomerulonephritis in interferon-γ receptor-deficient mice. J. Inflamm. 47:206.